Cynata Therapeutics Limited (CYP.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 03:47PM AEST
| Previous close | 0.1350 |
| Open | 0.1350 |
| Bid | 0.1350 x 1582700 |
| Ask | 0.1450 x 3535900 |
| Day's range | 0.1350 - 0.1450 |
| 52-week range | 0.1050 - 0.3850 |
| Volume | |
| Avg. volume | 94,831 |
| Market cap | 26.047M |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1100 |
| Earnings date | 25 July 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireDimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior Advisor
Dimension Inx, a biomaterials platform company developing therapeutics that restore tissue and organ function, announced today the appointments of Paul K. Wotton, Ph.D., to the board of directors and Chris Ehrlich as Senior Advisor.
Simply Wall St.We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
We Think Shareholders Are Less Likely To Approve A Pay Rise For Cynata Therapeutics Limited's (ASX:CYP) CEO For Now
The underwhelming share price performance of Cynata Therapeutics Limited ( ASX:CYP ) in the past three years would have...
© 2023 Yahoo. All rights reserved.
